ActivePhase 3ACTRN12605000279628

Interventions to improve participation in bowel cancer screening: the value of lay advocacy and positive framing of risk.


Sponsor

Prof. Graeme Young MD, FRACP

Enrollment

1,800 participants

Start Date

Jan 1, 2005

Study Type

Interventional

Conditions

Summary

Improved participation in screening for bowel cancer is desirable. Currently population scale bowel cancer screening program delivery is by mailed offer from a central screening service and invitations include a faecal occult blood detection kit. Invitees may decline the offer because they do not feel they are at risk, or because they do not engage with the program. We have developed invitation letters to that include either improved risk messages or messages from previous screening participants in order to overcome these barriers. We will randomly select invitees from the electoral roll and compare population screening participation between groups with or without the preliminary letter to determine which program results in the greater participation rate. Improved participation in screening will ultimately reduce deaths from bowel cancer


Eligibility

Sex: Both males and femalesMin Age: 50 YearssMax Age: 75 Yearss

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying interventions to improve participation in bowel cancer screening: the value of lay advocacy and positive framing of risk. You may be eligible if you are adults aged 50 to 75. People with people already participating in bowel cancer screening research and service programs coordinated from the bowel health service may not be able to participate. Participation may involve medical tests, study visits, and follow-up appointments.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Intervention 1: the use of a bowel cancer screening invitation letter to that contains photographs of 2 previous screenees who were diagnosed with early bowel cancer through their participation in a b

Intervention 1: the use of a bowel cancer screening invitation letter to that contains photographs of 2 previous screenees who were diagnosed with early bowel cancer through their participation in a bowel cancer screening program, and with simple program advocacy statements from them. Intervention 2: the use of a bowel cancer screening invitation letter that contains enhanced positive framing and generalised risk messages.


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12605000279628